CHPA is pleased to see FDA’s long-awaited draft guidance on innovative approaches for greater consumer access to nonprescription medicines, and applauds FDA’s focus on patient safety as a top priority.
Jul 17, 2018
By clicking the Accept button, you agree to us doing so.
